ECSP034549A - Formas cristalinas de 1-(6-cloro-5-(trifluorometil)-2-piridinil)piperazina hidrocloruro - Google Patents

Formas cristalinas de 1-(6-cloro-5-(trifluorometil)-2-piridinil)piperazina hidrocloruro

Info

Publication number
ECSP034549A
ECSP034549A EC2003004549A ECSP034549A ECSP034549A EC SP034549 A ECSP034549 A EC SP034549A EC 2003004549 A EC2003004549 A EC 2003004549A EC SP034549 A ECSP034549 A EC SP034549A EC SP034549 A ECSP034549 A EC SP034549A
Authority
EC
Ecuador
Prior art keywords
crystalline forms
trifluorometil
piridinil
chlorine
hydrochloride piperazine
Prior art date
Application number
EC2003004549A
Other languages
English (en)
Inventor
Patrick Carlier
Josef Cornelius Johannes Muyrers
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ECSP034549A publication Critical patent/ECSP034549A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/34—Trocars; Puncturing needles
    • A61B17/3403—Needle locating or guiding means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4887—Locating particular structures in or on the body
    • A61B5/489—Blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/34—Trocars; Puncturing needles
    • A61B17/3403—Needle locating or guiding means
    • A61B2017/3405—Needle locating or guiding means using mechanical guide means
    • A61B2017/3409—Needle locating or guiding means using mechanical guide means including needle or instrument drives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/34—Trocars; Puncturing needles
    • A61B17/3403—Needle locating or guiding means
    • A61B2017/3413—Needle locating or guiding means guided by ultrasound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/44—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for cooling or heating the devices or media

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

La invención se refiere a formas cristalinas A y B de 1-(6-CLORO-5-(TRIFLUOROMETIL)-2-PIRIDIL)PIPERAZINA HIDROCLORURO (Org 12962), a métodos de preparación de aquellas formas cristalinas y composiciones farmacéuticas que comprenden forma cristalina B utilizadas en el tratamiento de depresión, ansiedad, obesidad o incontinencia urinaria.
EC2003004549A 2000-10-13 2003-04-08 Formas cristalinas de 1-(6-cloro-5-(trifluorometil)-2-piridinil)piperazina hidrocloruro ECSP034549A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00203528 2000-10-13

Publications (1)

Publication Number Publication Date
ECSP034549A true ECSP034549A (es) 2003-05-26

Family

ID=8172124

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004549A ECSP034549A (es) 2000-10-13 2003-04-08 Formas cristalinas de 1-(6-cloro-5-(trifluorometil)-2-piridinil)piperazina hidrocloruro

Country Status (20)

Country Link
US (1) US20040038985A1 (es)
EP (1) EP1326837A1 (es)
JP (1) JP2004512282A (es)
KR (1) KR20030060906A (es)
CN (1) CN1469863A (es)
AU (1) AU2002220614A1 (es)
BR (1) BR0114609A (es)
CA (1) CA2425540A1 (es)
EC (1) ECSP034549A (es)
HR (1) HRP20030246A2 (es)
HU (1) HUP0302842A2 (es)
IL (1) IL154982A0 (es)
IS (1) IS6758A (es)
MX (1) MXPA03003233A (es)
NO (1) NO20031698D0 (es)
PL (1) PL366055A1 (es)
RU (1) RU2003113536A (es)
SK (1) SK4332003A3 (es)
WO (1) WO2002030902A1 (es)
ZA (1) ZA200302520B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008004945A1 (en) * 2006-07-04 2008-01-10 Astrazeneca Ab Novel crystalline forms i and ii
WO2008004944A1 (en) * 2006-07-04 2008-01-10 Astrazeneca Ab Novel crystalline form ii
CZ303950B6 (cs) * 2011-12-12 2013-07-10 Masarykova Univerzita Zpusob prípravy 1-(pyridin-4-yl)piperazinu a jeho 1,1-dialkyl-1-ium derivátu
WO2015066344A1 (en) 2013-11-01 2015-05-07 Arena Pharmaceuticals, Inc. 5-ht2c receptor agonists and compositions and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0370560B1 (en) * 1988-11-24 1994-01-12 Akzo Nobel N.V. Pharmaceutical composition containing 1-[mono- or bis (trifluoromethyl)-2-pyridinyl] piperazines
WO1998033504A1 (en) * 1997-02-03 1998-08-06 Akzo Nobel N.V. Treatment of urinary incontinence

Also Published As

Publication number Publication date
HRP20030246A2 (en) 2003-06-30
BR0114609A (pt) 2003-12-23
AU2002220614A1 (en) 2002-04-22
WO2002030902A8 (en) 2004-02-26
ZA200302520B (en) 2004-06-30
CN1469863A (zh) 2004-01-21
KR20030060906A (ko) 2003-07-16
MXPA03003233A (es) 2003-09-10
IS6758A (is) 2003-03-27
RU2003113536A (ru) 2004-11-10
JP2004512282A (ja) 2004-04-22
CA2425540A1 (en) 2002-04-18
SK4332003A3 (en) 2003-10-07
US20040038985A1 (en) 2004-02-26
WO2002030902A1 (en) 2002-04-18
EP1326837A1 (en) 2003-07-16
HUP0302842A2 (hu) 2003-12-29
PL366055A1 (en) 2005-01-24
NO20031698D0 (no) 2003-04-11
IL154982A0 (en) 2003-10-31

Similar Documents

Publication Publication Date Title
ATE407998T1 (de) Reinigungsmittel
ATE346039T1 (de) Sulfonamido-substituierte verbrückte bicycloalkylderivative
ATE340844T1 (de) Stabile, wässerige zusammensetzungen zur behandlung von oberflächen , insbesondere geweben
TW200612910A (en) Medicaments comprising carbonyl compounds, and the use thereof
SE0300010D0 (sv) Novel Compounds
CR8291A (es) Formas polimorficas 3-(4-amino-1-oxo-1,3 dihidro -isoindol-2-il)-piperidin-2, 6-diona
BR0317715A (pt) Composições e processos de uso de collajolie
SE0102315D0 (sv) Compounds
MX2007005408A (es) Compuestos de aminoquinazolinas.
MY144318A (en) Methods of treating hiv infection.
ES2421948T3 (es) Compuestos y composiciones para suministrar agentes activos
DE60209929D1 (de) Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
BRPI0512958A (pt) antagonistas de nk1
SE0101932D0 (sv) Pharmaceutical combinations
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
WO2004043362A3 (en) Acyl guanidine compounds and use thereof
UY27203A1 (es) Bencimidazoles útiles en el tratamiento de la disfunción sexual
SE0003476D0 (sv) Compounds
GEP20094801B (en) Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
WO2006034001A3 (en) Methods of treating hiv infection
DE60032517D1 (de) Heilmittel gegen durch endothelin verursachte erkrankungen
BR0317623A (pt) Escitalopram, composição farmacêutica, e, uso de hidrobrometo de escitalopram
SE0300445D0 (sv) New combination
ITMI20011002A0 (it) Composizioni per carburanti ecologici procedimenti di preparazione e l'impego delle stesse
BR0210632A (pt) Tratamento de doença parasìtica